Nerve Transfer Surgery for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a surgery called contralateral C7 root transfer (also known as contraligenic nerve transfer or CC7 nerve transfer) to assist individuals who have lost arm movement after a stroke. The goal is to determine if this surgery can improve arm function when other treatments have ceased to be effective. It suits those who had a stroke 1 to 5 years ago and continue to struggle with arm movement despite undergoing rehabilitation. As an unphased trial, this study provides a unique opportunity for patients to explore innovative treatment options that may enhance their recovery journey.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this nerve transfer surgery is safe for stroke recovery?
Research has shown that transferring a nerve from the healthy side of the body to the affected side is generally safe for stroke recovery. One study found that this procedure can improve hand function without causing issues in the healthy arm. Another study confirmed that patients experienced safe and lasting improvements even years after the surgery. This evidence suggests that the treatment is well-tolerated and does not lead to serious side effects.12345
Why are researchers excited about this trial?
Most treatments for spastic hemiparesis after a stroke focus on physical therapy, medications like muscle relaxants, or Botox injections to manage symptoms. However, the contralateral C7 root transfer is unique because it offers a surgical approach to potentially restore function. This treatment involves transferring a nerve from the unaffected side of the body to the affected side, aiming to rewire and rejuvenate muscle control. Researchers are excited about this technique because it directly addresses the underlying nerve damage, offering hope for more significant and sustained recovery beyond what current symptom-management strategies can achieve.
What evidence suggests that contralateral C7 root transfer might be an effective treatment for stroke recovery?
Research shows that contralateral C7 root transfer, a procedure participants in this trial will undergo, can greatly improve arm function in stroke patients. Studies have found that this nerve transfer reduces muscle stiffness in the affected arm, enhancing movement. One study reported a noticeable decrease in stiffness, improving patients' ability to use their arm. Another study confirmed the procedure's safety and effectiveness, with lasting improvements in arm function. Overall, evidence suggests that this treatment helps stroke patients regain better control and use of their arms.13467
Who Is on the Research Team?
Jennifer Hong, Dr.
Principal Investigator
Dartmouth-Hitchcock Medical Center
Are You a Good Fit for This Trial?
This trial is for stroke survivors with arm weakness or paralysis who haven't seen improvement after 1-5 years of rehab. It's not suitable for pregnant individuals.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo contralateral C7 root transfer surgery for the treatment of spastic hemiparesis
Follow-up
Participants are monitored for changes in arm function using the Fugl-Meyer upper-extremity scale
What Are the Treatments Tested in This Trial?
Interventions
- Contralateral C7 root transfer
Trial Overview
The study tests a surgical procedure called contralateral C7 root transfer, aiming to improve arm function in patients with spastic hemiparesis due to stroke.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
The C7 nerve root transfer will occur to the patients on this arm.
Contralateral C7 root transfer is already approved in China, United States, European Union for the following indications:
- Upper limb paralysis due to stroke
- Brachial plexus injury
- Upper limb paralysis due to stroke
- Traumatic brachial plexus injury
- Upper limb paralysis due to stroke
- Brachial plexus avulsion injury
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
Published Research Related to This Trial
Citations
Contralateral C7 Nerve Transfer for Stroke Recovery
In this work, we will review the available data on the safety and efficacy of C7 nerve transfer in stroke, the technique, and the associated ...
Contralateral seventh cervical nerve transfer for central spastic ...
In addition, the spasticity in the paralyzed upper extremity significantly improved in patients with CC7 transfer (SMD β1.42, 95% CI = β1.60 to ...
Case report Contralateral C7 nerve root transfer for post ...
Contralateral C7 nerve root transfer has been proven to improve post-stroke spastic arm function. In contrast, prolonged flaccidity is rare, ...
Reconstruction of paralyzed arm function in patients with ...
This study showed that CC7 cross transfer can provide effective, safe and stable functional improvements in long-term follow-up, and provided ...
Rewiring to Regain Function in Patients with Spastic ...
An experimental study of the treatment of root avulsion of brachial plexus using contralateral C7 nerve neurotization (nerve transfer). Zhonghua ...
Trial of Contralateral Seventh Cervical Nerve Transfer for ...
We randomly assigned 36 patients who had had unilateral arm paralysis for more than 5 years to undergo C7 nerve transfer plus rehabilitation (18 ...
evolution of the contralateral C7 transfer - Wendong Xu, 2025
This article presents a comprehensive review of contralateral C7 (cC7) transfer surgery, tracing its evolution from treating brachial plexus injuries to its ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.